Bristol-Myers Squibb (BMY)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 8 |
| Ownership rank: | 62 |
| % of all portfolios: | 0.118% |
| Hold Price * : | $60.65 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
2 |
$1,850,016 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Richard Pzena - Pzena Investment Management |
3.37 |
Reduce 4.72% |
17,095,731 |
1,036,856,000 |
| ≡ |
Hillman Capital Management |
2.24 |
Reduce 1.60% |
53,102 |
3,221,000 |
| ≡ |
Kahn Brothers Group |
1.83 |
Reduce 15.73% |
170,381 |
10,334,000 |
| ≡ |
Bill Miller - Miller Value Partners |
1.10 |
Reduce 35.65% |
69,500 |
4,215,000 |
| ≡ |
John Rogers - Ariel Investments |
0.49 |
Reduce 1.49% |
721,731 |
43,773,000 |
| ≡ |
Dodge & Cox Funds |
0.15 |
Reduce 34.69% |
4,622,820 |
280,374,000 |
| ≡ |
Tweedy Browne |
0.13 |
Add 55.31% |
26,158 |
1,586,000 |
| ≡ |
Mairs & Power Funds |
0.02 |
Reduce 2.96% |
24,200 |
1,468,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 29 Apr 2025 |
HIRAWAT SAMIT |
EVP,Chief Med.Offr.,Drug Dev. |
25 Apr 2025 |
4,250 |
47.58 |
202,215 |
| 21 Feb 2025 |
BOERNER CHRISTOPHER S. |
Chief Executive Officer |
20 Feb 2025 |
2,000 |
55.05 |
110,096 |
| 19 Feb 2025 |
HIRAWAT SAMIT |
EVP,Chief Med.Offr.,Drug Dev. |
14 Feb 2025 |
1,823 |
54.84 |
100,000 |
| 05 Nov 2024 |
HIRAWAT SAMIT |
EVP,Chief Med.Offr.,Drug Dev. |
01 Nov 2024 |
1,830 |
54.68 |
100,055 |
| 07 Dec 2023 |
BOERNER CHRISTOPHER S. |
Chief Executive Officer |
05 Dec 2023 |
2,000 |
49.78 |
99,560 |
| 30 Nov 2023 |
BOERNER CHRISTOPHER S. |
Chief Executive Officer |
28 Nov 2023 |
3,071 |
48.86 |
150,049 |
| 21 Nov 2023 |
SAMUELS THEODORE R. II |
Director |
20 Nov 2023 |
8,500 |
49.81 |
423,385 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock